| scholarly article | Q13442814 |
| P50 | author | Michael G Surette | Q90181766 |
| Douglas G Storey | Q56797129 | ||
| Kangmin Duan | Q38803382 | ||
| P2093 | author name string | Christopher D Sibley | |
| Harvey R Rabin | |||
| Michael D Parkins | |||
| Carrie Fischer | |||
| P2860 | cites work | Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease | Q22008612 |
| Plants and animals share functionally common bacterial virulence factors | Q24630477 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| Secreted Bacterial Effectors and Host-Produced Eiger/TNF Drive Death in aSalmonella-Infected Fruit Fly | Q24798117 | ||
| Bacterial activity in cystic fibrosis lung infections | Q24813737 | ||
| Vibrio cholerae infection of Drosophila melanogaster mimics the human disease cholera | Q24817194 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein | Q27861056 | ||
| A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
| The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults | Q28289939 | ||
| Common Virulence Factors for Bacterial Pathogenicity in Plants and Animals | Q28292772 | ||
| Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model | Q28297288 | ||
| Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis | Q28303994 | ||
| QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aeruginosa | Q28493121 | ||
| Pseudomonas aeruginosa relA contributes to virulence in Drosophila melanogaster | Q28493313 | ||
| Chromosomal genetics of Pseudomonas | Q29615288 | ||
| Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. | Q31030261 | ||
| Prevalence of local immune response against oral infection in a Drosophila/Pseudomonas infection model | Q33247461 | ||
| Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. | Q41481789 | ||
| A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. | Q42604401 | ||
| The Drosophila immune system detects bacteria through specific peptidoglycan recognition | Q44985652 | ||
| Relish, a central factor in the control of humoral but not cellular immunity in Drosophila | Q45007881 | ||
| Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. | Q45868836 | ||
| Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila | Q46061846 | ||
| Characterization and transcriptional profiles of a Drosophila gene encoding an insect defensin. A study in insect immunity | Q47072356 | ||
| The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila | Q47072446 | ||
| The road to Toll | Q47259322 | ||
| Two distinct pathways can control expression of the gene encoding the Drosophila antimicrobial peptide metchnikowin | Q48037223 | ||
| Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis | Q57913654 | ||
| Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions | Q73206292 | ||
| Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains | Q73301855 | ||
| Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis | Q33310144 | ||
| Insect immunity. Characterization of a Drosophila cDNA encoding a novel member of the diptericin family of immune peptides | Q33798288 | ||
| Profiling early infection responses: Pseudomonas aeruginosa eludes host defenses by suppressing antimicrobial peptide gene expression | Q33850542 | ||
| A mosaic analysis in Drosophila fat body cells of the control of antimicrobial peptide genes by the Rel proteins Dorsal and DIF. | Q33891087 | ||
| Drosophila host defense after oral infection by an entomopathogenic Pseudomonas species | Q33913963 | ||
| Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces | Q33927605 | ||
| The role of antimicrobial peptides in animal defenses | Q33988529 | ||
| Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects | Q33994325 | ||
| The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum | Q34016834 | ||
| The cecropin locus in Drosophila; a compact gene cluster involved in the response to infection | Q34147887 | ||
| Metchnikowin, a Novel Immune‐Inducible Proline‐Rich Peptide from Drosophila with Antibacterial and Antifungal Properties | Q34297748 | ||
| Identification of early genes in the Drosophila immune response by PCR-based differential display: the Attacin A gene and the evolution of attacin-like proteins | Q34310150 | ||
| Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. | Q34314919 | ||
| Drosophila lifespan enhancement by exogenous bacteria | Q34342471 | ||
| A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution | Q34350921 | ||
| Pulmonary infections in patients with cystic fibrosis | Q34561212 | ||
| Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. | Q34740991 | ||
| Mechanisms for induction of acquired host immunity by neutrophil peptide defensins | Q34835899 | ||
| An essential complementary role of NF-kappaB pathway to microbicidal oxidants in Drosophila gut immunity | Q34972763 | ||
| Drosophila immunity: paths and patterns | Q35031944 | ||
| Toll receptor-mediated Drosophila immune response requires Dif, an NF-kappaB factor | Q35193354 | ||
| Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. | Q35206063 | ||
| Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. | Q35638889 | ||
| Drosophila: the genetics of innate immune recognition and response | Q35698495 | ||
| Developing animal models for polymicrobial diseases | Q35805388 | ||
| Toll and IMD pathways synergistically activate an innate immune response in Drosophila melanogaster | Q35857132 | ||
| Sensing and signaling during infection in Drosophila | Q36010985 | ||
| Regulators of the Toll and Imd pathways in the Drosophila innate immune response | Q36083516 | ||
| Cooperation of Toll-like receptor signals in innate immune defence | Q36743540 | ||
| Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms | Q36827957 | ||
| Cystic fibrosis: a polymicrobial infectious disease | Q36895733 | ||
| Confronting physiology: how do infected flies die? | Q36947120 | ||
| characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling | Q37597340 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | Drosophila | Q312154 |
| P304 | page(s) | e1000184 | |
| P577 | publication date | 2008-10-24 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections | |
| P478 | volume | 4 |
| Q90239291 | "It Takes a Village": Mechanisms Underlying Antimicrobial Recalcitrance of Polymicrobial Biofilms |
| Q34280094 | A unique regulator contributes to quorum sensing and virulence in Burkholderia cenocepacia |
| Q34058686 | Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. |
| Q35230652 | Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis |
| Q38857862 | Aspergillus Biofilms in Human Disease. |
| Q35918209 | Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections |
| Q34486698 | Assessment of virulence diversity of methicillin-resistant Staphylococcus aureus strains with a Drosophila melanogaster infection model |
| Q39835134 | Azithromycin Paradox in the Treatment of Cystic Fibrosis Airway Disease |
| Q38103942 | Bacterial genome evolution within a clonal population: from in vitro investigations to in vivo observations |
| Q34548415 | Barrier immune effectors are maintained during transition from nurse to forager in the honey bee |
| Q52744402 | Biocompatibility of antimicrobials to maggot debridement therapy: medical maggots Lucilia sericata (Diptera: Calliphoridae) exhibit tolerance to clinical maximum doses of antimicrobials. |
| Q28493240 | Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl |
| Q34389339 | CHD1 contributes to intestinal resistance against infection by P. aeruginosa in Drosophila melanogaster |
| Q34442217 | Calcium chelation by alginate activates the type III secretion system in mucoid Pseudomonas aeruginosa biofilms |
| Q48163282 | Candida Species Biofilms' Antifungal Resistance. |
| Q36911444 | Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity |
| Q33566281 | Chemical modulators of the innate immune response alter gypsy moth larval susceptibility to Bacillus thuringiensis |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q91260289 | Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells |
| Q40442475 | Combinations and loads of bacteria affect the cytokine production by fetal membranes: An in vitro study. |
| Q36545573 | Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection |
| Q35027908 | Comparative pathology of bacteria in the genus Providencia to a natural host, Drosophila melanogaster |
| Q42575595 | Comparing the microbiota of the cystic fibrosis lung and human gut. |
| Q43245583 | Concentration-dependent activity of antibiotics in natural environments |
| Q40964077 | Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. |
| Q51276027 | Cuticular bacteria appear detrimental to social spiders in mixed but not monoculture exposure. |
| Q36909659 | Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors |
| Q26771468 | Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat |
| Q95276755 | Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities |
| Q36213685 | Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. |
| Q35665027 | Deconstructing host-pathogen interactions in Drosophila |
| Q33705998 | Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients |
| Q34059034 | Development of an ex vivo porcine lung model for studying growth, virulence, and signaling of Pseudomonas aeruginosa |
| Q34711995 | Discovery of trypanosomatid parasites in globally distributed Drosophila species |
| Q44922640 | Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection |
| Q33634104 | Drosophila melanogaster as a model host for the Burkholderia cepacia complex |
| Q90482754 | Drosophila melanogaster as a polymicrobial infection model for Pseudomonas aeruginosa and Staphylococcus aureus |
| Q27348828 | Drosophila melanogaster as an animal model for the study of Pseudomonas aeruginosa biofilm infections in vivo |
| Q64099175 | Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2 |
| Q33609099 | Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions. |
| Q35117696 | Environment and colonisation sequence are key parameters driving cooperation and competition between Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci |
| Q38005495 | Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections |
| Q40339646 | Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa |
| Q35317716 | First report of Wohlfahrtiimonas chitiniclastica from soft tissue and bone infection at an unusually high northern latitude |
| Q91900516 | Fly foregut and transmission of microbes |
| Q38266645 | Fungal biofilms in human disease. |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q33951943 | Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems |
| Q35955467 | Host-microbiome interactions in acute and chronic respiratory infections |
| Q28649612 | How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health |
| Q38635041 | How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? |
| Q37641493 | Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings. |
| Q59297522 | Hybrid sensor kinase PA1611 inPseudomonas aeruginosaregulates transitions between acute and chronic infection through direct interaction with RetS |
| Q36008282 | Immune response to bacteria induces dissemination of Ras-activated Drosophila hindgut cells |
| Q94561391 | In vitro Mixed Biofilm of Streptococcus suis and Actinobacillus pleuropneumoniae Impacts Antibiotic Susceptibility and Modulates Virulence Factor Gene Expression |
| Q58565205 | In vitro and ex vivo systems at the forefront of infection modeling and drug discovery |
| Q38831274 | In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. |
| Q26830891 | Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease |
| Q38992886 | Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use Antibiotics |
| Q38978571 | Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections |
| Q35930737 | Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization |
| Q35835658 | Integrated approach to understanding the onset and pathogenesis of black band disease in corals |
| Q48002479 | Interaction between Streptococcus pneumoniae and Staphylococcus aureus in paediatric patients suffering from an underlying chronic disease |
| Q41756431 | Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms |
| Q38847303 | Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections |
| Q34677317 | Interpreting infective microbiota: the importance of an ecological perspective. |
| Q34284493 | Interspecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms |
| Q33698085 | Lethality and developmental delay in Drosophila melanogaster larvae after ingestion of selected Pseudomonas fluorescens strains |
| Q37705435 | Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity |
| Q28741382 | Magnesium limitation is an environmental trigger of the Pseudomonas aeruginosa biofilm lifestyle |
| Q38192498 | Mechanisms of synergy in polymicrobial infections |
| Q37720396 | Medically important bacterial-fungal interactions |
| Q90598504 | Metabolic output defines Escherichia coli as a health-promoting microbe against intestinal Pseudomonas aeruginosa |
| Q39853469 | Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa |
| Q34541225 | Microbial communities of the upper respiratory tract and otitis media in children |
| Q33626876 | Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms |
| Q36757719 | Microbiology and treatment of acute apical abscesses |
| Q30394473 | Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response |
| Q36310773 | Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus. |
| Q38080967 | Molecular detection of CF lung pathogens: current status and future potential |
| Q37611830 | Molecular discrimination of mosquito vectors and their pathogens |
| Q37985256 | Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology |
| Q36410987 | Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus |
| Q59297524 | PA2800 Plays an Important Role in Both Antibiotic Susceptibility and Virulence in Pseudomonas aeruginosa |
| Q30988019 | Path analyses of cross-sectional and longitudinal data suggest that variability in natural communities of blood-associated parasites is derived from host characteristics and not interspecific interactions |
| Q37500602 | Pathogenesis of Fungal Infections in Cystic Fibrosis. |
| Q34297656 | Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients |
| Q34661901 | Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. |
| Q38220972 | Polybacterial human disease: the ills of social networking. |
| Q35666253 | Polymicrobial interactions: impact on pathogenesis and human disease |
| Q38678093 | Precision respiratory medicine and the microbiome |
| Q34011041 | Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes |
| Q37057719 | Promise for plant pest control: root-associated pseudomonads with insecticidal activities |
| Q35408861 | Pseudomonas aeruginosa RhlR is required to neutralize the cellular immune response in a Drosophila melanogaster oral infection model |
| Q35788879 | Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis. |
| Q28543599 | Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected] |
| Q47834256 | Pyrosequencing reveals the complex polymicrobial nature of invasive pyogenic infections: microbial constituents of empyema, liver abscess, and intracerebral abscess |
| Q37578893 | Quorum sensing and social networking in the microbial world. |
| Q57061954 | Rapid diversification of in cystic fibrosis lung-like conditions |
| Q40420487 | Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis |
| Q26797508 | Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice |
| Q34818539 | Respiratory microbiota: addressing clinical questions, informing clinical practice |
| Q34554419 | Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy |
| Q35570912 | Sharing of quorum-sensing signals and role of interspecies communities in a bacterial plant disease |
| Q38195929 | Small flies to tackle big questions: assaying complex bacterial virulence mechanisms using Drosophila melanogaster. |
| Q41407638 | Spoils of war: iron at the crux of clinical and ecological fitness of Pseudomonas aeruginosa. |
| Q41757360 | Staphylococcus aureus alters growth activity, autolysis, and antibiotic tolerance in a human host-adapted Pseudomonas aeruginosa lineage |
| Q37641808 | Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. |
| Q36304192 | Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa |
| Q30275462 | Systems-level metabolism of the altered Schaedler flora, a complete gut microbiota |
| Q35773518 | The Drosophila melanogaster host model |
| Q90040737 | The Intestine of Drosophila melanogaster: An Emerging Versatile Model System to Study Intestinal Epithelial Homeostasis and Host-Microbial Interactions in Humans |
| Q35721841 | The Microbiome: The Trillions of Microorganisms That Maintain Health and Cause Disease in Humans and Companion Animals |
| Q35743588 | The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway |
| Q92458688 | The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions |
| Q34437958 | The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations |
| Q57913623 | The airway microbiome in cystic fibrosis: challenges for therapy |
| Q28730299 | The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management |
| Q28070102 | The biogeography of polymicrobial infection |
| Q35861377 | The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy |
| Q33533638 | The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response |
| Q35987288 | The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications |
| Q35163645 | The evolving dynamics of the microbial community in the cystic fibrosis lung |
| Q40675590 | The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome |
| Q38130513 | The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection. |
| Q38274423 | The human microbiome: opportunities and challenges for clinical care |
| Q34710850 | The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection |
| Q37843465 | The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture |
| Q37501328 | The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. |
| Q34199591 | The role of the microbiome in exacerbations of chronic lung diseases |
| Q52869984 | The route of infection determines Wolbachia antibacterial protection in Drosophila. |
| Q60912410 | Transcriptional profiling of Pseudomonas aeruginosa and Staphylococcus aureus during in vitro co-culture |
| Q42344389 | Treating bacterial virulence systems: we are not there yet |
| Q35143420 | Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset |
| Q34113328 | Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration |
Search more.